North Melbourne, Australia

Suzanne Cory

This inventor holds 4 USPTO granted patents. Top assignees: Walter and Eliza Hall Institute of Medical Research, Cerylid Pty., Ltd.. Active years: 2004-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzanne Cory. Retrieved from https://idiyas.com/inventor/suzanne-cory

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2004-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Suzanne Cory: Innovator in Therapeutic Molecules**

Introduction

Suzanne Cory, a distinguished inventor based in North Melbourne, Australia, has made significant contributions to the field of medical research through her innovative work in therapeutic molecules. With a total of four patents to her name, Cory's research primarily focuses on molecules capable of modulating apoptosis in mammalian cells, which holds great promise for therapeutic applications.

Latest Patents

Cory's most recent patents delve into novel molecules that are crucial in the modulation of cell death and survival. One of her key inventions includes a member of the Bcl-2 family of proteins, known as 'Bim'. This work encompasses genetic sequences that encode these innovative molecules, which can be utilized in therapies, diagnostics, and screening tools aimed at influencing cell physiological processes. Another significant patent focuses on a mammalian gene, bcl-w, which promotes cell survival, indicating its potential in delaying cell cycle entry and regulation of apoptosis. These therapeutic molecules not only represent advancements in medical science but may also lead to the development of effective treatments for various diseases.

Career Highlights

Cory has had a notable career, contributing her expertise at prestigious research institutions. She has worked at the Walter and Eliza Hall Institute of Medical Research, where her research gained prominence within the scientific community. Furthermore, she has collaborated with Cerylid Pty., Ltd., further enhancing her impact on medicinal research and development.

Collaborations

Throughout her career, Cory has collaborated with notable scientists, including Jerry Adams and David C. S. Huang. These partnerships have undoubtedly enriched her research and contributed to her innovations in the field of apoptosis regulation and therapeutic intervention.

Conclusion

Suzanne Cory stands out as a key innovator in the realm of therapeutic molecules. Her contributions, highlighted by her patents and collaborations, reflect her dedication to advancing medical science. As research in apoptosis and cell survival continues to evolve, Cory's work will remain a vital part of the conversation surrounding innovative treatments and therapies for various conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…